Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 221

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action

Wood, Alastair J.J., Spitz, Irving M., Bardin, C.W.·1993·New England Journal of Medicine

Abstract

Antiprogestins, agents that inhibit the action of progesterone, are among the most controversial and yet the more interesting therapeutic compounds developed in the past 20 years. These agents provide the most effective and safest means of medical abortion, and in addition they may be used for the treatment of patients with cancer, Cushing's syndrome, and gynecologic disorders and for contraception. The first effective antiprogestin was mifepristone (also known as RU 486),1 a derivative of the progestin norethindrone (Figure 1). By analogy with the antiestrogens, it is likely that the substitution at the 11 beta position is responsible for the antiprogestin . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199308053290607

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 221

Metadata

Authors
Wood, A. J. J., Spitz, I. M., & Bardin, C. W.
Venue
New England Journal of Medicine
Published
1993-08-05
Volume
329
Issue
6
Pages
404-412
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2336040302
Cited by
221
References
2
FWCI
12.61
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action. https://app.cochat.ai/papers/10.1056/nejm199308053290607
The paper
Wood, A. J. J., Spitz, I. M., & Bardin, C. W. (1993). Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action. New England Journal of Medicine. https://doi.org/10.1056/nejm199308053290607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.